Cargando…
Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model
Type 2 diabetes mellitus (T2DM) is a risk factor for cognitive impairment. Ranolazine, an anti-ischemic drug used in the treatment of angina pectoris, has been shown to possess hypoglycemic properties in pre-clinical and clinical studies. The aim of this study was to evaluate the effects of ranolazi...
Autores principales: | Cassano, Velia, Leo, Antonio, Tallarico, Martina, Nesci, Valentina, Cimellaro, Antonio, Fiorentino, Teresa Vanessa, Citraro, Rita, Hribal, Marta Letizia, De Sarro, Giovambattista, Perticone, Francesco, Sesti, Giorgio, Russo, Emilio, Sciacqua, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071286/ https://www.ncbi.nlm.nih.gov/pubmed/32023991 http://dx.doi.org/10.3390/nu12020382 |
Ejemplares similares
-
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes
por: Cassano, Velia, et al.
Publicado: (2022) -
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects
por: Sciacqua, Angela, et al.
Publicado: (2020) -
Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease
por: Sesti, Giorgio, et al.
Publicado: (2014) -
Oxidative Stress and Left Ventricular Performance in Patients with Different Glycometabolic Phenotypes
por: Cassano, Velia, et al.
Publicado: (2022) -
Uric Acid Impairs Insulin Signaling by Promoting Enpp1 Binding to Insulin Receptor in Human Umbilical Vein Endothelial Cells
por: Tassone, Eliezer J., et al.
Publicado: (2018)